最新报道:Injective (INJ) is gaining attention as a potential candidate for the next staking-enabled altcoin ETF, following the success of similar products for Solana (SOL) and Ethereum (ETH). Analysts suggest that Injective's strong institutional backing, high staking yields (currently around 15%), and its role in decentralized finance (DeFi) make it an attractive option for ETF providers. The platform's focus on institutional-grade infrastructure and recent partnerships with traditional finance players could facilitate regulatory approval. If launched, an INJ ETF would provide investors with indirect exposure to staking rewards while avoiding the technical complexities of direct participation, potentially driving significant institutional capital into the ecosystem.